Epistaxis and oral anticoagulant therapy

Area of Science:

• Otolaryngology
• Cardiology
• Pharmacology

Background:

• Epistaxis (nosebleeds) presents unique challenges in patients undergoing long-term oral anticoagulant therapy.
• An aging population and increased prevalence of cardiovascular diseases contribute to a rising number of patients on anticoagulants.
• This demographic shift leads to a higher incidence of anticoagulant-related complications, including severe epistaxis.

Purpose of the Study:

• To review current literature and guidelines on managing epistaxis in anticoagulated patients.
• To propose a standardized management algorithm for this specific patient group.
• To address the complexities arising from concurrent anticoagulant use and epistaxis.

Main Methods:

• Comprehensive literature search of relevant studies and clinical guidelines.
• Analysis of current management practices for epistaxis in patients on oral anticoagulants.
• Development of a proposed standardized clinical algorithm.

Main Results:

• Current management strategies for epistaxis in anticoagulated patients are varied and often lack standardization.
• Oral anticoagulant therapy significantly complicates epistaxis management due to increased bleeding risk.
• A need exists for a structured approach to optimize patient outcomes.

Conclusions:

• Effective management of epistaxis in anticoagulated patients necessitates interdisciplinary collaboration.
• A standardized algorithm can provide a consistent and evidence-based framework for treatment.
• Implementing a structured approach is crucial for improving care and reducing complications.